‘Arteriosclerosis, Thrombosis, and Vascular Biology’ (no date a). Available at: https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.119.311996?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.
‘Arteriosclerosis, Thrombosis, and Vascular Biology’ (no date b). Available at: https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.110.207480.
‘Circulation Research’ (no date a). Available at: https://www.ahajournals.org/doi/full/10.1161/01.RES.0000252802.25497.b7.
‘Circulation Research’ (no date b). Available at: https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.116.309692.
‘Circulation Research’ (no date c). Available at: https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.116.308537.
‘Circulation Research’ (no date d). Available at: https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.117.312465.
De Backer, D. and Dorman, T. (2017) ‘Surviving Sepsis Guidelines’, JAMA, 317(8). Available at: https://doi.org/10.1001/jama.2017.0059.
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* | Ovid (2014). Available at: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00003246&LSLINK=80&D=jbi.
Evans, L. (2019) ‘A Closer Look at Sepsis-Associated Mortality’, JAMA Network Open, 2(2). Available at: https://doi.org/10.1001/jamanetworkopen.2018.7565.
Frangogiannis, N.G. (2019) ‘Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities’, Molecular Aspects of Medicine, 65, pp. 70–99. Available at: https://doi.org/10.1016/j.mam.2018.07.001.
Hafiane, A. and Daskalopoulou, S.S. (2018) ‘Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease’, Metabolism, 85, pp. 213–222. Available at: https://doi.org/10.1016/j.metabol.2018.04.008.
Howell, M.D. and Davis, A.M. (2017) ‘Management of Sepsis and Septic Shock’, JAMA, 317(8). Available at: https://doi.org/10.1001/jama.2017.0131.
Huang, S. and Frangogiannis, N.G. (2018) ‘Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges’, British Journal of Pharmacology, 175(9), pp. 1377–1400. Available at: https://doi.org/10.1111/bph.14155.
Knaus, W.A. and Marks, R.D. (2019) ‘New Phenotypes for Sepsis’, JAMA, 321(20). Available at: https://doi.org/10.1001/jama.2019.5794.
Komorowski, M. et al. (2018) ‘The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care’, Nature Medicine, 24(11), pp. 1716–1720. Available at: https://doi.org/10.1038/s41591-018-0213-5.
McPherson, D. et al. (2013) ‘Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010’, BMJ Open, 3(8). Available at: https://doi.org/10.1136/bmjopen-2013-002586.
Norman, D.C. (2000) ‘Fever in the Elderly’, Clinical Infectious Diseases, 31(1), pp. 148–151. Available at: https://doi.org/10.1086/313896.
Rhee, C. et al. (2019) ‘Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals’, JAMA Network Open, 2(2). Available at: https://doi.org/10.1001/jamanetworkopen.2018.7571.
Seymour, C.W. et al. (2019) ‘Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis’, JAMA, 321(20). Available at: https://doi.org/10.1001/jama.2019.5791.
Singer, M. et al. (2016) ‘The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)’, JAMA, 315(8). Available at: https://doi.org/10.1001/jama.2016.0287.
Sund-Levander, M., Forsberg, C. and Wahren, L.K. (2002) ‘Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review’, Scandinavian Journal of Caring Sciences, 16(2), pp. 122–128. Available at: https://doi.org/10.1046/j.1471-6712.2002.00069.x.
Westman, P.C. et al. (2016) ‘Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction’, Journal of the American College of Cardiology, 67(17), pp. 2050–2060. Available at: https://doi.org/10.1016/j.jacc.2016.01.073.
Wick, G. and Grundtman, C. (eds) (2012) Inflammation and Atherosclerosis. Vienna: Springer Vienna. Available at: https://doi.org/10.1007/978-3-7091-0338-8.
Zhou, S. et al. (2018) ‘miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges’, Acta Pharmacologica Sinica, 39(7), pp. 1073–1084. Available at: https://doi.org/10.1038/aps.2018.30.
